(Updated - April 14, 2020 6:34 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.30, $0.31 better than the analyst estimate of $1.99. Revenue for the quarter came in at $20.69 billion versus the consensus estimate of $19.44 billion.

GUIDANCE:

Johnson & Johnson sees FY2020 EPS of $7.50-$7.90, versus the consensus of $8.08. Johnson & Johnson sees FY2020 revenue of $77.5-80.5 billion, versus the consensus of $79.63 billion.

The impact of COVID-19, inclusive of the related investments the Company is making to combat the pandemic, is included in the guidance below.

	April 2020	January 2020
($ in Billions, except EPS)
Adjusted Operational Sales1,2 Change vs. Prior Year	(3.0%) - 0.5%	5.0% - 6.0%
Operational Sales2 Change vs. Prior Year	$79.2 to $82.2 (3.5%) - 0.0%	$85.8 to $86.6 4.5% - 5.5%
Estimated Reported Sales3 Change vs. Prior Year	$77.5 to $80.5 (5.5%) - (2.0%)	$85.4 to $86.2 4.0% - 5.0%
Adjusted Operational EPS (Diluted)2,4 Change vs. Prior Year	$7.65 to $8.05 (11.9%) - (7.3%)	$9.00 to $9.15 3.7% - 5.4%
Adjusted EPS (Diluted)3,4 Change vs. Prior Year	$7.50 to $7.90 (13.6%) - (9.0%)	$8.95 to $9.10 3.1% - 4.8%

With earnings, Johnson & Johnson raised its quarterly dividend $1.01 per share, or $4.04 annualized. This is a 6.3% increase from the prior dividend of $0.95. The dividend will be payable on June 9, 2020, to stockholders of record on May 26, 2020, with an ex-dividend date of May 22, 2020. The annual yield on the dividend is 2.8 percent.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.